LONG-TERM SURVIVAL IN ACUTE MYELOID-LEUKEMIA - THE-EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) EXPERIENCE

被引:38
|
作者
BENNETT, JM
ANDERSEN, JW
CASSILETH, PA
机构
[1] UNIV ROCHESTER,MED CTR,ROCHESTER,NY 14642
[2] HARVARD UNIV,SCH PUBL HLTH,DANA FARBER CANC INST,DIV BIOSTAT & EPIDEMIOL,BOSTON,MA 02115
[3] UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104
[4] HOSP UNIV PENN,DEPT MED,PHILADELPHIA,PA 19104
关键词
PROMYELOCYTIC LEUKEMIA; CURABILITY OF LEUKEMIA;
D O I
10.1016/0145-2126(91)90124-C
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A retrospective analysis of two ECOG adult AML trials conducted from 1976 to 1983 was carried out focusing on long term disease-free survival. This report summarizes the data on 545 patients with a minimum follow up of 7 1/2 years. The complete remission rate was 57% with an estimated cure rate of 12%. Of several prognostic variables examined only FAB type M3 (promyelocytic leukemia) was statistically significant (estimated cure rate of 33% vs 9% for other FAB subtypes).
引用
收藏
页码:223 / 227
页数:5
相关论文
共 50 条
  • [21] Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia - A study of the Eastern Cooperative Oncology Group (ECOG), E5995
    Gordon, MS
    Young, ML
    Tallman, MS
    Cripe, LD
    Bennett, JM
    Paietta, E
    Longo, W
    Gerad, H
    Mazza, J
    Rowe, JM
    LEUKEMIA RESEARCH, 2000, 24 (10) : 871 - 875
  • [22] Isolated intracranial recurrence in a patient with long-term survival of acute myeloid leukemia
    Huang, Haoxuan
    Cao, Pengfei
    Jiang, Xingjun
    Xie, Yuanyang
    ASIAN JOURNAL OF SURGERY, 2023, 46 (06) : 2517 - 2519
  • [23] Impacts of long-term illness: experience of young adults with Acute Myeloid Leukemia
    Barsaglini, Reni Aparecida
    Nunes de Siqueira Soares, Beluci Bianca
    CIENCIA & SAUDE COLETIVA, 2018, 23 (02): : 399 - 408
  • [24] ACUTE MYELOID-LEUKEMIA IN A BEHCETS-DISEASE PATIENT UNDER LONG-TERM THALIDOMIDE TREATMENT
    LOUZIR, B
    OTHMANI, S
    GRITLI, N
    BEJI, M
    ZIDI, B
    MSADDEK, F
    BOUSSEMA, E
    BAHRI, M
    ANNALES DE MEDECINE INTERNE, 1992, 143 (07): : 479 - 480
  • [25] Outcome of patients with acute promyelocytic leukemia (APL) in the pre-ATRA era: An analysis from the Eastern Cooperative Oncology Group (ECOG).
    Tallman, MS
    Kim, HT
    Andersen, JW
    Skeel, RT
    Sartiano, G
    Cassileth, PA
    Cripe, LD
    Wiernik, PH
    Rundhaugen, LM
    Rowe, JM
    BLOOD, 2002, 100 (11) : 766A - 766A
  • [26] Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
    Slovak, ML
    Kopecky, KJ
    Cassileth, PA
    Harrington, DH
    Theil, KS
    Mohamed, A
    Paietta, E
    Willman, CL
    Head, DR
    Rowe, JM
    Forman, SJ
    Appelbaum, FR
    BLOOD, 2000, 96 (13) : 4075 - 4083
  • [27] LONG-TERM BONE-MARROW CULTURE OF A MURINE MYELOID-LEUKEMIA
    RICHES, AC
    CHAPMAN, JN
    BRISCOE, CV
    HEPBURN, M
    MEDICAL SCIENCE RESEARCH-BIOCHEMISTRY, 1987, 15 (23-24): : 1461 - 1462
  • [28] LONG SURVIVAL IN AN ELDERLY PATIENT WITH ACUTE MYELOID-LEUKEMIA AFTER TREATMENT WITH HARRINGTONINE
    SULLIVAN, J
    LEYDEN, M
    MEDICAL JOURNAL OF AUSTRALIA, 1985, 142 (13) : 693 - 694
  • [29] LONG-TERM SURVIVAL IN ACUTE LEUKEMIA IN CHILDHOOD
    WILLIAMS, K
    SHORE, N
    HAMMOND, D
    HYMAN, C
    HIGGINS, G
    ORTEGA, J
    KARON, M
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 40 (06): : 973 - &
  • [30] 13-CIS-RETINOIC ACID IN THE TREATMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA - A PHASE-II PILOT-STUDY OF THE EASTERN COOPERATIVE ONCOLOGY GROUP
    KRAMER, ZB
    BOROS, L
    WIERNIK, PH
    ANDERSEN, J
    BENNETT, JM
    CASSILETH, P
    OKEN, M
    CANCER, 1991, 67 (06) : 1484 - 1486